| # | Drug | Count |
|---|---|---|
| 0 | PROGESTERONE | 3 |
| 1 | AMIFAMPRIDINE PHOSPHATE | 2 |
| 2 | VALPROATE SODIUM | 2 |
| 3 | ADALIMUMAB | 1 |
| 4 | AZATHIOPRINE | 1 |
| 5 | BELIMUMAB | 1 |
| 6 | CLONAZEPAM | 1 |
| 7 | DESVENLAFAXINE | 1 |
| 8 | DESVENLAFAXINE SUCCINATE | 1 |
| 9 | DOXYLAMINE SUCCINATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIFAMPRIDINE PHOSPHATE | 2 | 0.0007 |
| 1 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 2 | DOXYLAMINE SUCCINATE | 1 | 0.0002 |
| 3 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 4 | PROGESTERONE | 3 | 0.0001 |
| 5 | VALPROATE SODIUM | 2 | 0.0001 |
| 6 | LEUCOVORIN CALCIUM | 1 | 0.0001 |
| 7 | DESVENLAFAXINE SUCCINATE | 1 | 0.0000 |
| 8 | BELIMUMAB | 1 | 0.0000 |
| 9 | MODAFINIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Progesterone [EPC] | 3 | 0.0001 |
| 2 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 4 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 5 | Benzodiazepine [EPC] | 1 | 0.0000 |